Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
OneHQ launches hiring spree for anticipated growth
OneHQ, formerly NexusHQ, is beefing up its staff in anticipation of a projected revenue boom. The insurance and finance software company plans to add 13 employees — bringing its total headcount to 20 — in the next year as it anticipates more than doubling its annual revenue. The company reported revenue of more than $1 million…
Former Kauffman Foundation VP on how to scale via networking
With more than 25 years of leadership experience, Lesa Mitchell knows a thing or two about making — and fostering — valuable connections. Previously the vice president of innovation at the Ewing Marion Kauffman Foundation and a former executive at Marion Labs, Mitchell now is the founder of Networks for Scale, a company that works…
Windhaven Farms, Chemistry take 1 Million Cups stage
The seemingly disparate industries of agriculture and marketing were on display this week at 1 Million Cups with startups Windhaven Farms and Chemistry. Windhaven Farms founder Kristen Wolf first presented her local meat distribution company, which delivers an assortment of locally-raised, organically-grown meat products, including beef, pork, chicken and rabbit. “The product is really, really…